Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PlateletGenex Thrombocytopenia Panel (26 genes) (2 Day STAT TAT) Machaon Diagnostics United States | 22 | 26 |
|
Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia Genetic Pathology SA Pathology Australia | 1 | 1 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
RUNX1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Bone Marrow Failure / Anemia Panel Centogene AG - the Rare Disease Company Germany | 212 | 212 |
|
Invitae Multi-Cancer + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 142 | 63 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 754 | 562 |
|
Invitae Inherited Platelet Disorders Including Thrombocytopenia Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 70 | 50 |
|
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States | 16 | 65 |
|
Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 65 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 249 | 155 |
|
Inherited Bone Marrow Failure Panel PreventionGenetics, part of Exact Sciences United States | 266 | 186 |
|
Comprehensive HemeComplete Profile with IGH Somatic Hypermutation PathGroup United States | 13 | 161 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.